Results 71 to 80 of about 2,212 (184)

The role of IL-1 inhibition in systemic juvenile idiopathic arthritis: current status and future perspectives

open access: yesDrug Design, Development and Therapy, 2018
Nataša Toplak,1,2 Štefan Blazina,1 Tadej Avčin1,2 1Department of Allergology, Rheumatology and Clinical Immunology, University Children’s Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia; 2Faculty of Medicine ...
Toplak N, Blazina Š, Avčin T
doaj  

Chicoric acid regulates IL-1β to improve the inflammatory response in mice undergoing myomectomy under propofol anesthesia

open access: yesPakistan Journal of Pharmaceutical Sciences
Background: Surgical excision of uterine fibroids triggers acute inflammation, impacting postoperative recovery. Propofol anesthesia may modulate this response.
Zixuan Zhai, Zheng Zhao, Jianfeng Yu
doaj   +1 more source

Management of adult-onset Still’s disease with interleukin-1 inhibitors: evidence- and consensus-based statements by a panel of Italian experts

open access: yesArthritis Research & Therapy, 2019
Background Adult-onset Still’s disease (AOSD) is a rare inflammatory condition characterized by fever, rash, and arthritis. Because of its rarity, clinical trials are inherently small and often uncontrolled.
Serena Colafrancesco   +14 more
doaj   +1 more source

Effusive Constrictive Pericarditis in the Era of COVID-19

open access: yesAnnals of Internal Medicine: Clinical Cases
Effusive-constrictive pericarditis is a rare condition in which the visceral pericardium compresses the heart, with fluid accumulation in the pericardial space leading to cardiac tamponade.
Shriya Sharma   +6 more
doaj   +1 more source

Interleukin-1 (IL-1) inhibitors : anakinra, rilonacept, and canakinumab

open access: yes, 2016
Inhibitors of interleukin-1 (IL-1) are proteins which decrease the actions of the inflammatory cytokine, IL-1. There are two general mechanisms of IL-1 inhibitors: binding to the IL-1 receptor (anakinra) or binding directly to IL-1 (rilonacept and ...
Mahler, Stephen M.   +5 more
core   +1 more source

Muckle–Wells syndrome: clinical perspectives

open access: yesOpen Access Rheumatology: Research and Reviews, 2017
Tu-Anh Tran Department of Pediatrics, Nîmes University Hospital, INSERM U1183, Montpellier-Nîmes University, Nîmes, France Abstract: Muckle–Wells syndrome (MWS) is a rare autoinflammatory disorder.
Tran TA
doaj  

Therapeutic targeting of inflammasome signaling by blocking interleukin-1

open access: yes, 2023
The production of active interleukin-1 (IL-1) is a major outcome of inflammasome signaling causing local and systemic inflammation. IL-1-mediated inflammation contributes to the pathogenesis of many human diseases including autoinflammatory diseases ...
Coll, Rebecca C.; id_orcid
core   +1 more source

Deficiency of interleukin-1 receptor antagonist: An updated review of the pathogenesis, clinical characteristics, and treatments

open access: yesClinical Immunology Communications
Deficiency of Interleukin-1 receptor antagonist (DIRA) is a rare autosomal recessive autoinflammatory disease first reported in 2009. To date, 33 patients have been previously characterized and reported in literature.
Spencer Fang   +2 more
doaj   +1 more source

Anti-Interleukin-1 Agents in Adult Onset Still's Disease

open access: yesInternational Journal of Inflammation, 2012
Interleukin 1β (IL-1β) is emerging as a master mediator of adult onset Still’s disease (AOSD) pathogenesis. This pleiotropic cytokine, whose expression is under the control of the inflammasome pathway, has a wide type of effects.
Cecilia Giampietro, Bruno Fautrel
doaj   +1 more source

IL-1β Inhibition in Cardiovascular Complications Associated to Diabetes Mellitus

open access: yesFrontiers in Pharmacology, 2017
Diabetes mellitus (DM) is a chronic disease that affects nowadays millions of people worldwide. In adults, type 2 diabetes mellitus (T2DM) accounts for the majority of all diagnosed cases of diabetes.
Concepción Peiró   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy